Thelansis

  Coronaviruses (CoVs) are a family of RNA viruses grouped into three categories: α-CoVs, β-CoVs, and γ-CoVs. SARS-CoV-2, similar to MERS-CoV and SARS-CoV, belongs to the β-CoV group. These viruses have a large, enveloped, single-stranded RNA genome and encode four key structural proteins: spike (S), nucleocapsid (N), membrane (M), and envelope (E) proteins. Although coronaviruses primarily infect birds and mammals, some have jumped to humans, causing zoonotic diseases. SARS-CoV-2 primarily spreads through respiratory droplets and may be transmitted through eye contact or the fecal-oral route. COVID-19 severity varies, from mild cold-like symptoms to severe respiratory illness. Common symptoms include fever, cough, fatigue, and shortness of breath, with less frequent reports of headache, sore throat, hemoptysis, and diarrhea. FDA-approved treatments for COVID-19 include the IV antiviral Veklury (remdesivir), immune modulators Olumiant (baricitinib) and Actemra (tocilizumab), and ...

 Coronaviruses (CoVs) are a family of RNA viruses grouped into three categories: α-CoVs, β-CoVs, and γ-CoVs. SARS-CoV-2, similar to MERS-CoV and SARS-CoV, belongs to the β-CoV group. These viruses have a large, enveloped, single-stranded RNA genome and encode four key structural proteins: spike (S), nucleocapsid (N), membrane (M), and envelope (E) proteins. Although coronaviruses primarily infect birds and mammals, some have jumped to humans, causing zoonotic diseases. SARS-CoV-2 primarily spreads through respiratory droplets and may be transmitted through eye contact or the fecal-oral route. COVID-19 severity varies, from mild cold-like symptoms to severe respiratory illness. Common symptoms include fever, cough, fatigue, and shortness of breath, with less frequent reports of headache, sore throat, hemoptysis, and diarrhea. FDA-approved treatments for COVID-19 include the IV antiviral Veklury (remdesivir), immune modulators Olumiant (baricitinib) and Actemra (tocilizumab), and the...